✨ Free AI Report
Zymeworks Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Zymeworks Inc.
Research Preview

Zymeworks Inc.: Business Overview, Financials & Competitive Analysis

Zymeworks is a clinical-stage biotechnology company that discovers, develops, and commercializes biotherapeutics for the treatment of cancer and autoimmune and inflammatory diseases. Its therapeutic platforms and full...

Analyst-debate audio for Zymeworks Inc.

AskCyborg analysts argue the bull and bear cases for Zymeworks Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Zymeworks Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
5/ 10Mixed

Cyborg Score thesis

A clinical-stage biotech with differentiated antibody platforms and Big Pharma partnerships, but requires successful clinical...

Read the full analyst-debate transcript →
Industry Biotechnology / Biopharmaceuticals - Oncology and Immunotherapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Zymeworks Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Zymeworks Inc. Overview

Pro stress-test →

Zymeworks is a clinical-stage biotechnology company that discovers, develops, and commercializes biotherapeutics for the treatment of cancer and autoimmune and inflammatory diseases. Its therapeutic platforms and fully integrated drug development engine provide flexibility to precisely engineer and develop differentiated antibody-based therapeutic candidates.

Strategic Profile

Pro stress-test →

The company has strategic partnerships with major pharma including Merck Sharp & Dohme, Eli Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Daiichi Sankyo, Janssen Biotech, BeiGene, and Exelixis. Lead product zanidatamab is in Phase 1, Phase 2, and Phase 3 clinical trials, with zanidatamab zovodotin in Phase 2 trials for advanced HER2-expressing tumors.

Competitive Landscape

Pro stress-test →

Zymeworks competes in the clinical-stage antibody therapeutics space against other developers of bispecific and multifunctional antibody-based drugs. Major competitors include Regeneron, Genmab, Amgen, and other bispecific antibody developers, though Zymeworks differentiates through its proprietary platform technologies.

Industry Context

Zymeworks Inc. operates in Biotechnology / Biopharmaceuticals - Oncology and Immunotherapy.

Key facts

Founded: 2003 · Headquarters: Vancouver, Canada · Employees: 286 · Market cap: $384.52M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Zymeworks Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Zymeworks Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Bispecific AntibodiesDevelops bispecific antibodies for oncology and other therapeutic areas→Bispecific AntibodiesLeading provider of bispecific antibody platform technology→Antibody-Drug ConjugatesDevelops ADCs for cancer treatment→

Compare Zymeworks Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Zymeworks Inc. operates in Biotechnology / Biopharmaceuticals - Oncology and Immunotherapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology / Biopharmaceuticals - Oncology and Immunotherapy research →
NEW · MCP server

Ask your AI assistant about Zymeworks Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Zymeworks Inc. and its top competitor on Cyborg Score”
“What did Zymeworks Inc. do this quarter?”
“Is Zymeworks Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Zymeworks Inc. do?+
Zymeworks is a clinical-stage biotechnology company that discovers, develops, and commercializes biotherapeutics for the treatment of cancer and autoimmune and inflammatory diseases. Its therapeutic platforms and full...
What is Zymeworks Inc.'s Cyborg Score?+
Zymeworks Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Zymeworks Inc.'s main competitors?+
Named competitors include Bispecific Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates. The full competitive landscape is in the AskCyborg report.
How can I get the full Zymeworks Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Zymeworks Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Zymeworks Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Dave Inc.9nVent Electric plc9Elbit Systems Ltd.9Vertiv Holdings Co9Barrick Mining Corporation9GE Vernova Inc.9Applied Materials, Inc.9Eli Lilly and Company9Microsoft Corporation8Dätwyler Holding AG8Cingulate Inc.8Tristel plc8cBrain8Electrovaya Inc.8Kits Eyecare Ltd.8Sukoon Insurance8Lumax Industries Limited8Tanla Platforms Limited